Literature DB >> 8329384

Identification and structural analysis of the tetrasaccharide NeuAc alpha(2-->6)Gal beta(1-->4)GlcNAc beta(1-->3)Fuc alpha 1-->O-linked to serine 61 of human factor IX.

R J Harris1, H van Halbeek, J Glushka, L J Basa, V T Ling, K J Smith, M W Spellman.   

Abstract

O-Linked fucose has been found attached to Thr/Ser residues within the sequence Cys-X-X-Gly-Gly-Thr/Ser-Cys in the N-terminal EGF domains of several coagulation/fibrinolytic proteins. Carbohydrate composition and mass spectrometric analyses of tryptic and thermolytic peptides containing the corresponding site (Ser-61) in the first EGF domain of human factor IX indicated the presence of a tetrasaccharide containing one residue each of sialic acid, galactose, N-acetylglucosamine, and fucose. The Ser-61 tetrasaccharide was not susceptible to alpha-fucosidase digestion. Fragments generated during mass spectrometric analysis indicated that fucose was the attachment sugar residue. The involvement of fucose in the carbohydrate-peptide linkage was confirmed by two-dimensional 1H NMR spectroscopic analysis of the glycopeptide containing factor IX residues 57-65. The complete structure of the tetrasaccharide was obtained by methylation analysis and two-dimensional 1H TOCSY and ROESY experiments as NeuAc alpha(2-->6)Gal beta(1-->4)GlcNAc beta(1-->3)Fuc alpha 1-->O-Ser61.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8329384     DOI: 10.1021/bi00077a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Structural elucidation of O-linked glycopeptides by high energy collision-induced dissociation.

Authors:  K F Medzihradszkyaff; B L Gillece-Castroaff; R R Townsendaff; A L Burlingameaff; M R Hardyaff
Journal:  J Am Soc Mass Spectrom       Date:  1996-04       Impact factor: 3.109

Review 2.  The multiple roles of epidermal growth factor repeat O-glycans in animal development.

Authors:  Amanda R Haltom; Hamed Jafar-Nejad
Journal:  Glycobiology       Date:  2015-07-14       Impact factor: 4.313

Review 3.  Carbohydrates in cellular recognition: from leucine-zipper to sugar-zipper?

Authors:  D Spillmann
Journal:  Glycoconj J       Date:  1994-06       Impact factor: 2.916

4.  Novel roles for O-linked glycans in protein folding.

Authors:  Deepika Vasudevan; Robert S Haltiwanger
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

5.  Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk.

Authors:  Geun-Cheol Gil; William H Velander; Kevin E Van Cott
Journal:  Glycobiology       Date:  2008-05-02       Impact factor: 4.313

6.  Neural and synaptic defects in slytherin, a zebrafish model for human congenital disorders of glycosylation.

Authors:  Yuanquan Song; Jason R Willer; Paul C Scherer; Jessica A Panzer; Amy Kugath; Emmanuel Skordalakes; Ronald G Gregg; Gregory B Willer; Rita J Balice-Gordon
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

7.  First epidermal growth factor-like domain of human blood coagulation factor IX is required for its activation by factor VIIa/tissue factor but not by factor XIa.

Authors:  D Zhong; K J Smith; J J Birktoft; S P Bajaj
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways.

Authors:  Shaolin Shi; Pamela Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

9.  Regulation of glycan structures in murine embryonic stem cells: combined transcript profiling of glycan-related genes and glycan structural analysis.

Authors:  Alison V Nairn; Kazuhiro Aoki; Mitche dela Rosa; Mindy Porterfield; Jae-Min Lim; Michael Kulik; J Michael Pierce; Lance Wells; Stephen Dalton; Michael Tiemeyer; Kelley W Moremen
Journal:  J Biol Chem       Date:  2012-09-17       Impact factor: 5.157

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.